Anqi Lin

4.6k total citations · 5 hit papers
146 papers, 2.5k citations indexed

About

Anqi Lin is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anqi Lin has authored 146 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Oncology, 53 papers in Molecular Biology and 37 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anqi Lin's work include Cancer Immunotherapy and Biomarkers (47 papers), Ferroptosis and cancer prognosis (19 papers) and Immune Cell Function and Interaction (13 papers). Anqi Lin is often cited by papers focused on Cancer Immunotherapy and Biomarkers (47 papers), Ferroptosis and cancer prognosis (19 papers) and Immune Cell Function and Interaction (13 papers). Anqi Lin collaborates with scholars based in China, Hong Kong and United States. Anqi Lin's co-authors include Peng Luo, Jian Zhang, Quan Cheng, Ting Wei, Zaoqu Liu, Hui Meng, Aimin Jiang, Chaozheng Zhou, Zaoqu Liu and Hao Wu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLANT PHYSIOLOGY.

In The Last Decade

Anqi Lin

128 papers receiving 2.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer

2020 246 citations Anqi Lin, Jian Zhang et al. profile →
Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database

2023 114 citations Chaozheng Zhou, Anqi Lin et al. profile →
CTLs heterogeneity and plasticity: implications for cancer immunotherapy

2024 62 citations Anqi Lin, Aimin Jiang et al. profile →
Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review

2024 54 citations Aimin Jiang, Anqi Lin et al. profile →
From chaos to order: optimizing fecal microbiota transplantation for enhanced immune checkpoint inhibitors efficacy

2025 34 citations Anqi Lin, Aimin Jiang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anqi Lin China	28	1.1k	782	630	522	381	146	2.5k
Xiaochun Zhang China	32	581 0.5×	1.2k 1.5×	785 1.2×	279 0.5×	592 1.6×	122	3.5k
Zhuowei Hu China	30	314 0.3×	1.0k 1.3×	589 0.9×	530 1.0×	338 0.9×	97	3.0k
Ling Peng China	24	580 0.5×	498 0.6×	368 0.6×	174 0.3×	240 0.6×	126	1.6k
Nan Chen China	28	769 0.7×	436 0.6×	1.2k 2.0×	252 0.5×	201 0.5×	143	2.9k
Zhiqiang Wu China	28	344 0.3×	1.2k 1.5×	333 0.5×	217 0.4×	836 2.2×	136	2.7k
Yoko Shimada Japan	26	568 0.5×	1.1k 1.4×	610 1.0×	107 0.2×	480 1.3×	101	2.5k
Shixiang Wang China	22	586 0.5×	638 0.8×	335 0.5×	381 0.7×	375 1.0×	59	1.6k
Madhumita Das India	17	710 0.7×	866 1.1×	410 0.7×	636 1.2×	268 0.7×	65	2.7k
Li Lu United States	30	806 0.7×	1.1k 1.3×	259 0.4×	1.4k 2.7×	150 0.4×	101	4.1k
Bo Huang United States	29	1.5k 1.4×	598 0.8×	466 0.7×	793 1.5×	303 0.8×	115	3.4k

Countries citing papers authored by Anqi Lin

Since Specialization

Citations

This map shows the geographic impact of Anqi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anqi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anqi Lin more than expected).

Fields of papers citing papers by Anqi Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anqi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anqi Lin. The network helps show where Anqi Lin may publish in the future.

Co-authorship network of co-authors of Anqi Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Anqi Lin. A scholar is included among the top collaborators of Anqi Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anqi Lin. Anqi Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Kexin, et al.. (2025). Artificial Intelligence Revolutionizes Anti‐Infective Drug Discovery: From Target Identification to Lead Optimization. 1(2).

Lin, Anqi, et al.. (2025). A bi-directional flow weighted regression for interpreting social media sentiment identified by large language models. International Journal of Geographical Information Systems. 40(4). 1189–1221.

Gao, Zhifei, Aimin Jiang, Zizhuo Li, et al.. (2025). Heterogeneity of Intratumoral Microbiota Within the Tumor Microenvironment and Relationship to Tumor Development. SHILAP Revista de lepidopterología. 1(1). 32–61. 10 indexed citations

Jiang, Tong, Aimin Jiang, Qi Chang, et al.. (2025). Performance analysis of large language models in multi-disease detection from chest computed tomography reports: a comparative study. International Journal of Surgery. 111(8). 5071–5087. 1 indexed citations

Li, Zhengrui, Aimin Jiang, Jinghong Chen, et al.. (2025). Immunotherapy-induced cholestasis in cancer: insights from the two real-world pharmacovigilance databases of FAERS and VigiBase. International Journal of Surgery. 111(8). 5105–5121. 2 indexed citations

Lin, Anqi, et al.. (2025). MendelR: A One‐Stop R Toolkit for Mendelian Randomization Analysis.

Lin, Anqi, Aimin Jiang, Xufeng Huang, et al.. (2025). The Evolving Landscape of Immunotoxicity: Charting Mechanisms and Future Strategies for Immune Checkpoint Inhibitor Adverse Events. SHILAP Revista de lepidopterología. 1(3). 322–358. 2 indexed citations

Chen, Li, Anqi Lin, Bufu Tang, et al.. (2025). The Future of Cancer Therapy: Nanomaterials and Tumor Microenvironment. 1(1). 3 indexed citations

Lin, Anqi, et al.. (2025). FastUKB: A Revolutionary Tool for Simplifying UK Biobank Data Analysis. 1(1). 1 indexed citations

10.

Liang, Junyi, et al.. (2025). A multi-gene predictive model for the radiation sensitivity of nasopharyngeal carcinoma based on machine learning. eLife. 13.

11.

Jiang, Aimin, et al.. (2025). Re: HIF Regulates Multiple Translated Endogenous Retroviruses: Implications for Cancer Immunotherapy. European Urology. 88(4). 419–420.

12.

Wang, Chong, Anqi Lin, Yifeng Zhou, et al.. (2024). Mutation in FvPAL2 leads to light red strawberry fruits and yellow-green petioles. Plant Science. 352. 112370–112370. 2 indexed citations

13.

Chen, Jinghong, Anqi Lin, & Peng Luo. (2024). Advancing pharmaceutical research: A comprehensive review of cutting-edge tools and technologies. Current Pharmaceutical Analysis. 21(1). 1–19. 34 indexed citations

14.

Xu, Pengbo, Chao Ma, Xinyu Li, et al.. (2024). Loss-of-function mutation in anthocyanidin reductase activates the anthocyanin synthesis pathway in strawberry. SHILAP Revista de lepidopterología. 4(1). 33–33. 9 indexed citations

15.

Jiang, Aimin, Jinxin Li, Ying Liu, et al.. (2024). Renal cancer: signaling pathways and advances in targeted therapies. SHILAP Revista de lepidopterología. 5(8). e676–e676. 9 indexed citations

16.

Zhu, Lingxuan, Weiming Mou, Yancheng Lai, et al.. (2024). The Evaluation of Generative AI Should Include Repetition to Assess Stability. JMIR mhealth and uhealth. 12. e57978–e57978. 10 indexed citations

17.

Yang, Hong, Anqi Lin, Zaoqu Liu, et al.. (2024). PESSA: A web tool for pathway enrichment score-based survival analysis in cancer. PLoS Computational Biology. 20(5). e1012024–e1012024. 2 indexed citations

18.

Lin, Anqi, et al.. (2023). How does urban heat island differ across urban functional zones? Insights from 2D/3D urban morphology using geospatial big data. Urban Climate. 53. 101787–101787. 64 indexed citations

19.

Zhou, Chaozheng, et al.. (2023). Profiles of immune infiltration in seasonal allergic rhinitis and related genes and pathways. International Immunopharmacology. 120. 110174–110174. 2 indexed citations

20.

Lin, Anqi, Ting Wei, Mengyao Li, et al.. (2022). CAMOIP: a web server for comprehensive analysis on multi-omics of immunotherapy in pan-cancer. Briefings in Bioinformatics. 23(3). 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact